Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • whole genome bisulfite sequencing in mouse: how many reads required

    Hi,

    I am going to do some WGBS in mouse, before I start, could you give an idea how many reads I need in order to have a good CpG coverage? or how many lanes of hiseq2000 per sample should I do?

    Thanks

  • #2
    I would recommend looking at “NIH RoadMap Epigenomics Mapping Consortium” website: http://www.roadmapepigenomics.org/

    As a ball point figure they recommend minimum of two biological replicates/treatment with combined 30x coverage (15x/strand). Most of available kits will result in fairly short insert (100-150 bp) bisulphite converted libraries suitable for 2x50 cycle sequencing. Assuming a 3 Gb mouse genome and 180 M read/lane output, each treatment will need approximately 5 lanes of HiSeq sequencing to obtain minimum recommended coverage.Taking into account mapping efficiency of 60-70% will increase lane number by 1.5-2 totalling 6.5-7 lane/treatment. So, for control and one treatment minimum of 13 lanes sequencing is required.

    Comment


    • #3
      It depends on what you want to do with the data. I have a dataset where I used a single flow-cell with one sample per lane. That'd be about the minimum I could ever recommend. Your mapping efficiency should be upwards of 80% with mouse data, though you'll end up using a smaller portion of that if you QC things properly. I ended up with ~6x CpG coverage per-sample (in total >30x).

      Depending on what you're doing, you might consider targeted bisulfite sequencing. There's now a mouse kit to target promoters and such (note, this isn't RRBS), so that might be a nice alternative. The costs and analysis can both become a bit more appealing then.

      Comment


      • #4
        thanks guys

        Originally posted by nucacidhunter View Post
        I would recommend looking at “NIH RoadMap Epigenomics Mapping Consortium” website: http://www.roadmapepigenomics.org/

        As a ball point figure they recommend minimum of two biological replicates/treatment with combined 30x coverage (15x/strand). Most of available kits will result in fairly short insert (100-150 bp) bisulphite converted libraries suitable for 2x50 cycle sequencing. Assuming a 3 Gb mouse genome and 180 M read/lane output, each treatment will need approximately 5 lanes of HiSeq sequencing to obtain minimum recommended coverage.Taking into account mapping efficiency of 60-70% will increase lane number by 1.5-2 totalling 6.5-7 lane/treatment. So, for control and one treatment minimum of 13 lanes sequencing is required.
        Originally posted by dpryan View Post
        It depends on what you want to do with the data. I have a dataset where I used a single flow-cell with one sample per lane. That'd be about the minimum I could ever recommend. Your mapping efficiency should be upwards of 80% with mouse data, though you'll end up using a smaller portion of that if you QC things properly. I ended up with ~6x CpG coverage per-sample (in total >30x).

        Depending on what you're doing, you might consider targeted bisulfite sequencing. There's now a mouse kit to target promoters and such (note, this isn't RRBS), so that might be a nice alternative. The costs and analysis can both become a bit more appealing then.

        Comment

        Latest Articles

        Collapse

        • seqadmin
          Essential Discoveries and Tools in Epitranscriptomics
          by seqadmin




          The field of epigenetics has traditionally concentrated more on DNA and how changes like methylation and phosphorylation of histones impact gene expression and regulation. However, our increased understanding of RNA modifications and their importance in cellular processes has led to a rise in epitranscriptomics research. “Epitranscriptomics brings together the concepts of epigenetics and gene expression,” explained Adrien Leger, PhD, Principal Research Scientist...
          Yesterday, 07:01 AM
        • seqadmin
          Current Approaches to Protein Sequencing
          by seqadmin


          Proteins are often described as the workhorses of the cell, and identifying their sequences is key to understanding their role in biological processes and disease. Currently, the most common technique used to determine protein sequences is mass spectrometry. While still a valuable tool, mass spectrometry faces several limitations and requires a highly experienced scientist familiar with the equipment to operate it. Additionally, other proteomic methods, like affinity assays, are constrained...
          04-04-2024, 04:25 PM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by seqadmin, 04-11-2024, 12:08 PM
        0 responses
        58 views
        0 likes
        Last Post seqadmin  
        Started by seqadmin, 04-10-2024, 10:19 PM
        0 responses
        53 views
        0 likes
        Last Post seqadmin  
        Started by seqadmin, 04-10-2024, 09:21 AM
        0 responses
        45 views
        0 likes
        Last Post seqadmin  
        Started by seqadmin, 04-04-2024, 09:00 AM
        0 responses
        55 views
        0 likes
        Last Post seqadmin  
        Working...
        X